Hematological Cancers Global Clinical Trials Review, Q4, 2010

Date: December 1, 2010
Pages: 75
Price:
US$ 1,000.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: H7A20B92EE2EN
Leaflet:

Download PDF Leaflet

Hematological Cancers Global Clinical Trials Review, Q4, 2010
Hematological Cancers Global Clinical Trials Review, Q4, 2010

Summary

GlobalData's clinical trial report, “ Hematological Cancers Global Clinical Trials Review, Q4, 2010” provides data on the Hematological Cancers clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Hematological Cancers. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Hematological Cancers).

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope
  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy
  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
List of Tables
List of Figures
Introduction
Hematological Cancers
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Hematological Cancers
Subjects Recruited Over a Period of Time
Enrollment Trends by Phase for the Last Decade
Prominent Sponsors
Top Companies Participating in Hematological Cancers Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Janssen Pharmaceutical, Inc.
Clinical Trial Overview of Janssen Pharmaceutical, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
EntreMed, Inc.
Clinical Trial Overview of EntreMed, Inc.
Synta Pharmaceuticals Corp.
Clinical Trial Overview of Synta Pharmaceuticals Corp.
Piramal Life Sciences Limited
Clinical Trial Overview of Piramal Life Sciences Limited
Maxygen, Inc.
Clinical Trial Overview of Maxygen, Inc.
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
EMD Serono, Inc.
Clinical Trial Overview of EMD Serono, Inc.
Scios Inc.
Clinical Trial Overview of Scios Inc.
Cell Therapeutics, Inc.
Clinical Trial Overview of Cell Therapeutics, Inc.
ZIOPHARM Oncology, Inc.
Clinical Trial Overview of ZIOPHARM Oncology, Inc.
Infinity Pharmaceuticals, Inc.
Clinical Trial Overview of Infinity Pharmaceuticals, Inc.
Gamida Cell Ltd.
Clinical Trial Overview of Gamida Cell Ltd.
Hoffmann-La Roche Inc.
Clinical Trial Overview of Hoffmann-La Roche Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
medac GmbH
Clinical Trial Overview of medac GmbH
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Clinical Trial Overview of Top Universities / Institutes / Hospitals
National Cancer Institute (NCI)
Clinical Trial Overview of National Cancer Institute (NCI)
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Fred Hutchinson Cancer Research Center-Technology Transfer
Clinical Trial Overview of Fred Hutchinson Cancer Research Center-Technology Transfer
National Heart, Lung, and Blood Institute
Clinical Trial Overview of National Heart, Lung, and Blood Institute
Stanford University
Clinical Trial Overview of Stanford University
St. Jude Children’s Research Hospital, Inc.
Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc.
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Emory University
Clinical Trial Overview of Emory University
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Virginia Commonwealth University
Clinical Trial Overview of Virginia Commonwealth University
University Hospital of Liege
Clinical Trial Overview of University Hospital of Liege
Charite University
Clinical Trial Overview of Charite University
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
Indiana University School of Medicine
Clinical Trial Overview of Indiana University School of Medicine
University of Michigan Comprehensive Cancer Center
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
Thomas Jefferson University
Clinical Trial Overview of Thomas Jefferson University
Asan Medical Center
Clinical Trial Overview of Asan Medical Center
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source 74

LIST OF TABLES

Hematological Cancers Therapeutics Market, Global, Clinical Trials by Zone, 2010*
Hematological Cancers Therapeutics Market, Global, Clinical Trials by Top Countries, 2010*
Hematological Cancers Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010*
Hematological Cancers Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2010*
Hematological Cancers Therapeutics Clinical Trials, Europe, Top Five Countries, 2010*
Hematological Cancers Therapeutics Clinical Trials, North America, Top Countries, 2010*
Hematological Cancers Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2010*
Hematological Cancers Therapeutics Clinical Trials, Central and South America, Top Countries, 2010*
Hematological Cancers Therapeutics Clinical Trials, BRIC Countries, 2010*
Hematological Cancers Therapeutics Market, Global, Clinical Trials by Phase, 2010*
Hematological Cancers Therapeutics Market, Global, Clinical Trials in Progress by Phase 2010*
Hematological Cancers Therapeutics Market, Global, Clinical Trials by Trial Status, 2010*
Hematological Cancers Therapeutics Market, Global, Suspended Clinical Trials, 2010*
Hematological Cancers Therapeutics Market, Global, Withdrawn Clinical Trials, 2010*
Hematological Cancers Therapeutics Market, Global, Terminated Clinical Trials, 2010*
Hematological Cancers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009
Hematological Cancers Therapeutics Clinical Trials, Global, Enrollment Target Trends by Phase and Year, 2001-2010*
Hematological Cancers Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
Hematological Cancers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010*
Hematological Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceutical, Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by EntreMed, Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Synta Pharmaceuticals Corp., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Piramal Life Sciences Limited, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Maxygen, Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by EMD Serono, Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Scios Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Therapeutics, Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by ZIOPHARM Oncology, Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Gamida Cell Ltd., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by medac GmbH, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-Technology Transfer, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Liege, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2010*
Hematological Cancers Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2010* 71

LIST OF FIGURES

Hematological Cancers Therapeutics Market, Global, Clinical Trials by Zone (%), 2010*
Hematological Cancers Therapeutics Market, Global, Clinical Trials by Top Countries, 2010*
Hematological Cancers Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010*
Hematological Cancers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010*
Hematological Cancers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010*
Hematological Cancers Therapeutics Clinical Trials, North America, Top Countries (%), 2010*
Hematological Cancers Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2010*
Hematological Cancers Therapeutics Clinical Trials, BRIC Countries (%), 2010*
Hematological Cancers Therapeutics Market, Global, Clinical Trials by Phase (%), 2010*
Hematological Cancers Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010*
Hematological Cancers Therapeutics Market, Global, Clinical Trials by Trial Status, 2010*
Hematological Cancers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009
Hematological Cancers Therapeutics Clinical Trials, Global, Enrollment Target Trends by Phase and Year, 2001-2010*
Hematological Cancers Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
Hematological Cancers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010*
Hematological Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
GlobalData Methodology 73

Ask Your Question

Hematological Cancers Global Clinical Trials Review, Q4, 2010
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: